Precigen (PGEN) FCF Margin (2012 - 2026)
Precigen's (PGEN) quarterly FCF Margin came in at 189.34% in Q1 2026, up 107442.0% year-on-year from N/an in Q1 2025, and up 36.56% on a QoQ basis from 298.47% in Q4 2025.
Precigen (PGEN) FCF Margin (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of FCF Margin data on file, last reported at 189.34% in Q1 2026.
- On a quarterly basis, FCF Margin rose 107442.0% year-over-year to 189.34% in Q1 2026; TTM through Mar 2026 was 355.97%, a 80980.0% increase from a year earlier, with the FY2025 full-year figure at 927.57%, up 81801.0% from the prior year.
- FCF Margin for Q1 2026 stood at 189.34%, up from 298.47% in the prior quarter.
- Over the last five years, FCF Margin for PGEN reached as high as 106.22% in Q4 2022 and fell as low as 2361500.0% in Q3 2024.
- Historically, FCF Margin has averaged 256342.49% across 5 years, with a median of 1084.6% in 2023.
- Across the five-year window, FCF Margin sank 172420546 bps in 2023 and jumped 235823121 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 106.22% in 2022, then tumbled by 1315 bps to 1289.98% in 2023, then jumped by 98 bps to 27.86% in 2024, then plunged by 971 bps to 298.47% in 2025, then surged by 37 bps to 189.34% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 189.34% in Q1 2026, 298.47% in Q4 2025, and 3268.79% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -189.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -189.34% |
| Dec 31, 2025 | -298.47% |
| Sep 30, 2025 | -3,268.79% |
| Jun 30, 2025 | -2,382.71% |
| Mar 31, 2025 | -1,263.76% |
| Dec 31, 2024 | -27.86% |
| Sep 30, 2024 | -2,361,500.00% |
| Jun 30, 2024 | -3,546.72% |
| Mar 31, 2024 | -1,731.55% |
| Dec 31, 2023 | -1,289.98% |
| Sep 30, 2023 | -1,724,400.00% |
| Jun 30, 2023 | -905.43% |
| Dec 31, 2022 | 106.22% |
| Sep 30, 2022 | -194.54% |
| Jun 30, 2022 | -241.70% |
| Mar 31, 2022 | -345.26% |
| Dec 31, 2021 | 108.51% |
| Sep 30, 2021 | -578.70% |
| Jun 30, 2021 | -235.12% |
| Mar 31, 2021 | -70.98% |